Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$20,978,936
+$1,191,275 QoQ
Shares Held
82,604
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.22%
of 13F equity value
Holder Rank
#721
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. JNJ ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,978,936 | 82,604 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $19,787,661 | 80,951 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,374,487 | 83,955 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $14,405,279 | 77,690 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $11,286,544 | 73,889 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $12,027,214 | 72,523 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $10,740,492 | 74,267 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $12,710,203 | 78,429 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $11,731,239 | 80,263 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $12,863,377 | 81,316 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $12,544,371 | 80,033 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $12,475,574 | 80,100 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $13,596,971 | 82,147 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $13,748,500 | 88,700 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $16,183,966 | 91,616 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,118,804 | 92,549 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $17,257,521 | 97,220 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $17,281,164 | 97,507 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,896,945 | 87,081 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,362,356 | 88,931 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $14,945,704 | 90,723 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $14,788,048 | 89,979 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $13,869,425 | 88,127 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $13,422,572 | 90,157 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $11,511,970 | 81,860 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $10,737,970 | 81,888 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||